Combo parasite preventative gets FDA green lightFebruary 28, 2020Zoetis has received U.S. Food and Drug Administration (FDA) approval for a parasite preventative that protects dogs from fleas, ticks, and worms.
SPONSORED CONTENTLife Gets Busy, Stay ON POINT With Cytopoint®Simplify your approach to allergic pruritus with Cytopoint. Help maintain control of allergic itch when schedules get hectic for both veterinarians and pet owners alike. + Learn more
Diagnostics growth drives Zoetis' latest acquisitionFebruary 14, 2020Four months after venturing into the world of reference laboratory services, Zoetis has bolstered its presence within the space through the acquisition of Ethos Diagnostic Science.
Zoetis expands diagnostics capabilities with ZNLabs acquisitionNovember 27, 2019Zoetis has strengthened its diagnostics portfolio with the acquisition of ZNLabs, a full-service veterinary clinical reference laboratory company.
Zoetis strengthens diagnostics services through acquisitionNovember 1, 2019Zoetis has thrown its hat into the ring of reference laboratory services with the acquisition of Phoenix Central Laboratory for Veterinarians.
American Humane recognizes veterinary heroesOctober 7, 2019Two animal health-care professionals were praised as heroes at the ninth annual American Humane Hero Dog Awards.
Zoetis scholarships reward excellence, leadershipOctober 2, 2019Zoetis and the Association of American Veterinary Medical Colleges (AAVMC) will partner once again in 2020 to provide scholarships to second- and third-year veterinary students in the U.S. and the Caribbean.
Zoetis, Purina, Merck team up for diabetes campaignAugust 30, 2019November is Pet Diabetes Month, and the Diabetes Pet Care Alliance is once again encouraging veterinarians to enroll their clinics in their program.
Veterinarians urged to discuss skin health with clientsJuly 30, 2019Recent years have seen a rash of skin conditions in pets, and Zoetis is urging animal health professionals to speak up on the issue.
Zoetis strengthens equine portfolio with acquisitionJuly 25, 2019Zoetis Inc., has entered into an agreement to purchase Platinum Performance. The acquisition aims to strengthen Zoetis’s nutritional offerings, particularly within the equine market.
FDA approves ProHeart 12July 8, 2019The U.S. Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) has approved ProHeart 12 (moxidectin) extended release injectable suspension for dogs one year and older.
